首页> 外国专利> Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells

Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells

机译:用于检测和治疗与晶体粘附于肾细胞有关的肾脏疾病的方法和组合物

摘要

An autocrine crystal adhesion inhibitor called CAI is an anionic, sialic acid-containing glycoprotein secreted by kidney epithelial cells that blocks adhesion of calcium oxalate monohydrate (COM) crystals to the cell surfaces. Novel amino acid sequences are shown for the amino-acid terminus and 6 interval fragments. Persons may be classified according to risk of developing kidney stones, by measuring the amount of CAI in a biological sample. Treatment efficacy is also monitored by this method. CAI is administered in vivo to prevent nephrolithiasis. A rapid, simple assay to detect agents that inhibit adhesion of COM crystals to the surface of kidney epithelial cells is characterized.
机译:一种称为CAI的自分泌晶体粘附抑制剂是肾脏上皮细胞分泌的一种含唾液酸的阴离子糖蛋白,可阻止草酸钙一水合物(COM)晶体粘附至细胞表面。显示了氨基酸末端和6个间隔片段的新氨基酸序列。通过测量生物样品中CAI的量,可以根据患肾结石的风险对人进行分类。还通过这种方法监测治疗效果。体内施用CAI可预防肾结石病。一种快速,简单的检测试剂盒可检测抑制COM晶体粘附于肾上皮细胞表面的药物。

著录项

  • 公开/公告号US2003158115A1

    专利类型

  • 公开/公告日2003-08-21

    原文格式PDF

  • 申请/专利权人 LIESKE JOHN C.;TOBACK F. GARY;

    申请/专利号US20020299043

  • 发明设计人 F. GARY TOBACK;JOHN C. LIESKE;

    申请日2002-11-18

  • 分类号C12Q1/00;C07K7/08;A61K38/10;

  • 国家 US

  • 入库时间 2022-08-22 00:10:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号